The new 2010 AHA Guidelines no longer recommend the use of atropine in caring for patients with cardiac arrest. While it may be useful in vagally-mediated bradycardias, the evidence does NOT support the use of atropine in patients with asystole or PEA; therefore, it has been removed from the cardiac arrest algorithm.
